1
0
0
(1 - 21 von 22
)
Simplified urinary steroid profiling by LC-MS as diagnostic ...x-mol.com
newsletter.x-mol.com
— ... Andreas Floren 2 , Thomas Dandekar 2 , Anna Riester 3 , Ulrich Dischinger 4 , Max Kurlbaum 1 , Matthias Kroiss 5 , Martin Fassnacht 1.
Simulating the Post-gastric Bypass Intestinal Microenvironment ...www.cell.com › iscience › pdf
www.cell.com
· Max Kurlbaum,3 Matthias Kroiss,3 Christoph Otto,1 Carel W. le Roux,4 Tulika Arora,5 Florian Seyfried,1 and Nicolas Schlegel1,*. SUMMARY.
Download Figures (PPT)
www.cell.com
Mohammed K. Hankir, Theresa Langseder, Ezgi Eyluel Bankoglu, Yalda Ghoreishi, Ulrich Dischinger, Max Kurlbaum, Matthias Kroiss, Christoph Otto, ... › iscience › ppt
Tumorspezifische Steroid-Metabolome bei Nebennierentumoren
www.med.uni-wuerzburg.de
AG Martin Fassnacht / Matthias Kroiss / Max Kurlbaum Industriepartner: Chromsystems Instruments & Chemicals. Hintergrund und Stand der ...
[PDF] targeted metabolomics in patients before and after tumor removalscholar.archive.org › downloadpdf › journals › eje › EJE
scholar.archive.org
Zoran Erlic, Max Kurlbaum,. Felix Beuschlein, Matthias Kroiss: These authors contributed equally to this study (shared first and senior authorship). All authors ...
Method-Specific Cortisol and Dexamethasone Thresholds ...ProQuest
search.proquest.com
von N Vogg · · Zitiert von: 17 — Nora Vogg,a,b Max Kurlbaum,a,b Timo Deutschbein,a,c Benedict Grä sl,a Martin Fassnacht,a,b and. Matthias Kroiss a,b,d,*. BACKGROUND:.
Simplified urinary steroid profiling by LC-MS as diagnostic tool for ...www.sciencedirect.com › science › article › pii
www.sciencedirect.com
· Max Kurlbaum a b , Matthias Kroiss a d 1 , Martin Fassnacht a b Max Kurlbaum: Supervision, Funding acquisition, Writing – review & editing.
Klinische & experimentelle Studien - Nebennierenkarzinomwww.nebennierenkarzinom.de › forschung--studien › klinische-studien-ex...
www.nebennierenkarzinom.de
Arbeitsgruppe: PD Dr. Matthias Kroiss,. Dr. Max Kurlbaum. in Kooperation mit ENS@T und dem Institut für Pharmakologie der Uniklinik Köln. Publikationen ...
TP1 WP1: Tumorspezifische Steroid-Metabolome bei ...www.bayfor.org › forschungsverbuende › project › fortither › tp1-wp1-tu...
www.bayfor.org
AG Martin Fassnacht / Matthias Kroiss / Max Kurlbaum Industriepartner: Chromsystems Instruments & ChemicalsHintergrund und Stand der Forschung ...
Yalda Ghoreishi - PubFacts
www.pubfacts.com
Mohammed K Hankir Theresa Langseder Ezgi Eyluel Bankoglu Yalda Ghoreishi Ulrich Dischinger Max Kurlbaum Matthias Kroiss Christoph Otto Carel W le Roux ... › author
Drug Synergism of Proteasome Inhibitors and Mitotane by OUCIouci.dntb.gov.ua › works
ouci.dntb.gov.ua
Max Kurlbaum, Silviu Sbiera, Sabine Kendl, M. Martin Fassnacht, Matthias Kroiss. https://doi.org a · , Experimental and Clinical ...
Method-Specific Cortisol and Dexamethasone Thresholds Increase ...search.proquest.com › openview › 1.pdf
search.proquest.com
Nora Vogg,a,b Max Kurlbaum,a,b Timo Deutschbein,a,c Benedict Grä sl,a Martin Fassnacht,a,b and. Matthias Kroiss a,b,d,*. BACKGROUND: The dexamethasone ...
Drug Synergism of Proteasome Inhibitors and Mitotane by ...www.sigmaaldrich.com › tech-docs › paper
www.sigmaaldrich.com
· by Matthias Kroiss, Silviu Sbiera, Sabine Kendl, Max Kurlbaum, Martin Fassnacht. Hormones & cancer. Read more related scholarly scientific
A method for the minimally invasive drug monitoring PubAgUnited States Department of Agriculture (.gov)
pubag.nal.usda.gov
von B Friedl · · Zitiert von: 14 — Author: Bettina Friedl, Max Kurlbaum, Matthias Kroiss, Martin Fassnacht, Oliver Scherf-Clavel; Source: Analytical and bioanalytical chemistry v
A method for the minimally invasive drug monitoring of ...Gale
go.gale.com
von B Friedl · · Zitiert von: 14 — Author(s): Bettina Friedl 1 , Max Kurlbaum 2 3 , Matthias Kroiss 2 4 , Martin Fassnacht 2 4 , Oliver Scherf-Clavel 1. Author Affiliations:.
Objective Response and Prolonged Disease Control of Advanced...
mdanderson.elsevierpure.com
· Matthias Kroiss, Felix Megerle, Max Kurlbaum, Sebastian Zimmermann, Julia Wendler, Camilo Jimenez, Constantin Lapa, Marcus Quinkler, ...
Quantification of cobimetinib, cabozantinib, dabrafenib OUCI
ouci.dntb.gov.ua
von SD Krens · Zitiert von: 19 — Sebastian Zimmermann, Max Kurlbaum, Stefanie Mayer, Martin Fassnacht, Matthias Kroiss, Oliver Scherf-Clavel. https://doi.org ftd ·. › works
Simplified urinary steroid profiling by LC-MS as diagnostic ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von N Vogg · — ... Tobias Müller , Andreas Floren , Thomas Dandekar , Anna Riester , Ulrich Dischinger , Max Kurlbaum , Matthias Kroiss , Martin Fassnacht ... von I Balonov · — Authors. Ilja Balonov , Max Kurlbaum , Ann-Cathrin Koschker , Christine Stier , Martin Fassnacht , Ulrich Dischinger ...
Targeted metabolic profiling of urinary steroids with a focus on ...
pubmed.ncbi.nlm.nih.gov
von N Vogg · — Nora Vogg , Tobias Müller , Andreas Floren , Thomas Dandekar , Oliver Scherf-Clavel , Martin Fassnacht , Matthias Kroiss , Max Kurlbaum ... von N Isberner · — ... Aghai-Trommeschlaeger , Sebastian Zimmermann , Max Kurlbaum , Alicja Puszkiel , Benoit Blanchet , Hartwig Klinker , Oliver Scherf-Clavel ... › ...
Endocrinology and Metabolism
e-enm.org
— Nora Vogg, Max Kurlbaum, Timo Deutschbein, Benedict Gräsl, Martin Fassnacht, Matthias Kroiss. Clinical Chemistry.2021; 67(7): › journal › CitedBy
Method-Specific Cortisol and Dexamethasone Thresholds ...Semantic Scholar
www.semanticscholar.org
— author={Nora Vogg and Max Kurlbaum and Timo Deutschbein and Benedict Gr{\"a}sl and Martin Fassnacht and Matthias Kroiss}, journal={Clinical ...
Alle Infos zum Namen "Max Kurlbaum"
sortiert nach Relevanz / Datum